Skip to main content
Log in

Primary aldosteronism

  • Views
  • Facts, perspectives and opinions on selected topics
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Conn J.W. The evolution of primary aldosteronism: 1954–1967, Harvey Lectures, 62: 257, 1968.

    Google Scholar 

  2. Conn J.W., Cohen E.L., Rovner D.R. Suppression of plasma renin activity in primary aldosteronism: distinguishing primary from secondary aldosteronism in hypertensive disease. J. Am. Med. Ass. 190: 213, 1964.

    CAS  Google Scholar 

  3. Conn J.W., Cohen E.L., Rovner D.R., Nesbit R.M. Normokalaemic primary aldosteronism, a detectable cause of curable “essential” hypertension. J. Am. Med. Ass. 193: 200, 1965.

    Article  CAS  Google Scholar 

  4. Kaplan N.M. Commentary on incidence of primary aldosteronism. Current estimations based on objective data. Arc. Intern. Med. 123: 152, 1969.

    CAS  Google Scholar 

  5. Fishman L.M., Kuchal O., Liddle G.W., Michelakis A.M., Gordon R.D., Chick W.T. “Incidence of primary aldosteronism in uncomplicated “essential” hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria”. J. Am. Med. Ass. 205: 497, 1968.

    Article  CAS  Google Scholar 

  6. Ganguly A., Dowdy A.J., Luctscher J.A., Melada G.A. Anomalous postural response of plasma aldosterone concentration in patients with aldosterone-producing adrenal adenoma. J. Clin. Endocrinol. Metab. 36: 401, 1973.

    Article  PubMed  CAS  Google Scholar 

  7. Wisgerhof M., Brown R.D., Hogan M.J., Carpenter P.C., Edis A.J. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism. J. Clin. Endocrinol. Metab. 52: 195, 1981.

    Article  PubMed  CAS  Google Scholar 

  8. Ganguly A., Melada G.A., Luctscher J.A., Dowdy A.J. Control of plasma aldosterone in primary aldosteronism: distinction between adenoma and hyperplasia. J. Clin. Endocrinol. Metab. 37: 765, 1973.

    Article  PubMed  CAS  Google Scholar 

  9. Gordon R.D., Hamlet S.M., Tunny T.J., Klemm S.A. Aldosterone-producing adenomas responsive to angiotensin pose problems in diagnosis. Clin. Exp. Pharmacol. Physiol. 14: 175, 1982.

    Article  Google Scholar 

  10. Gordon R.D., Gomez-Sanchez C.E., Hamlet S.M., Tunny T.J., Klemm S.A. Angiotensin-responsive aldosterone-producing adenomas masquerades as idiopathic hyperaldosteronism (IHA: adrenal hyperplasia) or low-renin essential hypertension. J. Hypertension. 5(Suppl 5): S103, 1987.

    CAS  Google Scholar 

  11. Tunny T.J., Gordon R.D., Klemm S.A., Cohn D. Histological as well as biochemical distinctiveness of atypical aldosterone-producing adenomas responsive to upright posture and angiotensin. Clin. Endocrinol. 34: 363, 1991.

    Article  CAS  Google Scholar 

  12. Gordon R.D., Stowasser M., Tunny T.J., Klemm S.A., Finn W.L., Krek A.L. Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin. & Exper. Pharm. & Physiol. 18: 283, 1991.

    Article  CAS  Google Scholar 

  13. Gordon R.D., Stowasser M., Klemm S.A., Tunny T.J. Primary aldosteronism and other forms of mineralocorticoid hypertension. In: Textbook of Hypertension. Ed. Swales J.D. Blackwell. Scientific. 865, 1995.

  14. Gordon R.D., Klemm S.A., Tunny T.J., Stowasser M. Primary aldosteronism: hypertension with a genetic basis. Lancet 340: 159, 1992.

    Article  PubMed  CAS  Google Scholar 

  15. Gordon R.D., Stowasser M., Klemm S.A., Tumly T.J. Primary aldosteronism — some genetic, morphological, and biochemical aspects of subtypes. Steroids 60: 35, 1995.

    Article  PubMed  CAS  Google Scholar 

  16. Gordon R.D. Mineralocorticoid hypertension. Lancet. 344: 240, 1994.

    Article  PubMed  CAS  Google Scholar 

  17. Iida A., Blake K., Tunny T., Klemm S., Stowasser M., Hayward N., Gordon R., Nakamura Y., Imai T. Allelic losses on chromosome band 11q 13 in aldosterone producing adrenal tumors. Genes., Chromosomes. & Cancer. 12: 73, 1995.

    Article  CAS  Google Scholar 

  18. Clarke D., Wilkinson R., Johnston I.D.A., Hacking P.M., Haggith P.M. Severe hypertension in primary aldosteronism and good response to surgery. Lancet 1: 482, 1979.

    Article  PubMed  CAS  Google Scholar 

  19. Murphy B.F., Whitworth JA, Kincaid-Smith P. Malignant hypertension due to an aldosterone-producing adrenal adenoma. Clin. Exp. Hypertens. Theory. Pract. A 7: 939, 1985.

    Article  CAS  Google Scholar 

  20. Robertson P.W., Klidjian A., Harding L.K., Walters G., Lee M.R., Robb-Smith A.H.T. Hypertension due to a renin-secreting tumour. Am. J. Med. 43: 963, 1967.

    Article  PubMed  CAS  Google Scholar 

  21. Corvol P., Pinet F., Galen F.X., Plovin P.F., Chatellier G., Pagney J.Y., Bruneval P., Camilleri J.P., Menard J. Primary reninism. In Laragh J.H., Brenner B.M. (Eds), Hypertension: Pathophysiology, Diagnosis and Management, p. 1573 Raven Press, New York. 1995.

    Google Scholar 

  22. Gordon R.D., Klemm S.A., Tunny T.J., Stowasser M. Genetics of primary aldosteronism. Clin. & Exper. Pharm. & Physiol. 21: 915, 1994.

    Article  CAS  Google Scholar 

  23. Davies C.J., Joplin G.F., Wclbourn R.B. Surgical management of the ectopic ACTH syndrome. Ann.Surg. 196: 46, 1982.

    Article  Google Scholar 

  24. Jex R.K., van Heerden J.A., Carpenter P.C., Grant C.S. Ectopic ACTH syndrome. Diagnostic and therapeutic aspects. Am. J. Surg. 149: 276, 1985.

    Article  PubMed  CAS  Google Scholar 

  25. Findling J.W., Tyrrell J.B. Occult ectopic secretion of corticotropine. Arch. Intern. Med. 146: 929, 1986.

    Article  PubMed  CAS  Google Scholar 

  26. Biglieri E.C. Spectrum of mineralocorticoid hypertension. Hypertension 18: 251, 1991.

    Article  Google Scholar 

  27. Molhuysen J.A., Gerbrandy J., de Vries L.A., De Jong J.C., Lenstra J.B., Turner K.P., Borst J.G.G. A licorice extract with desoxycortone-like action. Lancet. ii: 381, 1950.

    Article  Google Scholar 

  28. Conn J.W., Rovner D.R., Cohen E.L. Licorice-induced pseudoaldosteronism. J. Am. Med. Ass. 205: 492, 1968.

    Article  CAS  Google Scholar 

  29. Cumming A.M.M., Boddy K., Brown J.J., Fraser R., Lever A.F., Padfield P.L., Robertson J.I.S. Severe hypokalaemia with paralysis induced by small doses of licorice. Postgrad. Med. J. 56: 526, 1980.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  30. Ulick S., Levine L.S., Gunezler P., Zanconato G., Ramirez L.C., Raugh W. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J. Clin. Endocrinol. Metab. 49: 757, 1979.

    Article  PubMed  CAS  Google Scholar 

  31. Stewart P.M., Corrie J.E.T., Shackleton C.H.L., Edwards C.R.W. Syndrome of apparent mineralocorticoid excess: a defect in the cortisol — cortisone shuttle. J. Clin. Invest. 82: 349, 1988.

    Article  Google Scholar 

  32. Shackleton C.H.L., Stewart P.M. The hypertension of apparent mineralocorticoid excess (AME) syndrome. In: Biglieri EG, Melby JC. eds. Endocrine hypertension. Raven. Press; p 153, 1990.

  33. Shimkets R.A., Warnoch D.G., Bositis C.M., Nelson-Williams C., Hansson J.H., Schambelan M., Gill J.R., Ulick S., Milora R.V., Findling J.W., Canessa C.M., Rossier B.C., Lifton R.P. Liddle’s syndrome: Heritable human hypertension caused by mutations in the β subunit of the epitheliai sodium channel. Cell. 79: 409, 1994.

    Article  Google Scholar 

  34. Gordon R.D., Klemm S.A., Tunny T.J. Renin in Liddle’s syndrome and in the syndrome of apparent mineralocorticoid excess. In: Robertson J.I.S., Nicholls M.G. (eds) The Renin-Angiotensin System. London, Gower Medical Publishing, 1993.

    Google Scholar 

  35. Hiramatsu K., Yamada T., Yukimura Y., Komiya I, Ichikawa K., Ishihara M. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch. Intern. Med. 141: 1589, 1981.

    Article  PubMed  CAS  Google Scholar 

  36. Anonymous. The early diagnosis of primary aldosteronism. JAMA 201: 20, 1967.

  37. Hamlet S.M., Tunny T.J., Woodland E., Gordon R.D. Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin. Exp. Pharmacol. Physiol. 12: 249, 1985.

    Article  PubMed  CAS  Google Scholar 

  38. Lins P.-E., Adamson U. Plasma aldosterone-plasma renin activity ratio. A simple test to identify patients with primary aldosteronism. Acta. Endocrinologica 113: 564, 1986.

    CAS  Google Scholar 

  39. Gordon R.D., Ziesak M.D., Tunny T.J., Stowasser M., Klemm S.A. Evidence that primary aldosteronism may not be uncommon — twelve percent incidence among antihypertensive drug trial volunteers. Clin. Exp. Pharmacol. Physiol. 20: 296, 1993.

    Article  PubMed  CAS  Google Scholar 

  40. Gordon R.D., Klemm S.A., Tunny T.J., Stowasser M. Gordon’s Syndrome: A sodium-volume-dependent form of hypertension with a genetic basis. In: Hypertension: Pathophysiology, diagnosis and management. 2nd ed. Laragh JH & Brenner BM (eds.) 1995; Raven Press, New York.

    Google Scholar 

  41. Nadler J.L., Horton R, Hsueh W. Therapeutic effect of calcium blockade in primary aldosteronism (Abstract). Clin. Res. 32: 21A, 1984.

    Google Scholar 

  42. Iimura O., Kikuchi K., Shimamoto K., Nozawa A., Hasegawa R., Homma C. Effects of nisoldipine on sympathetic activity, the renin-angiotensin-aldosterone system, and watersodium-calcium metabolism in patients with essential hypertension. Arzheim-Forsch/DrugRes. 39: 710, 1989.

    CAS  Google Scholar 

  43. Staessen J., Lijnen P., Fagard R., Hespel P., Tan W.P., Devos P., Amery A. Effect of the calcium entry blocker isradipine (PN 200-110) in essential hypertension. J. Cardiovasc. Pharmacol. 13: 271, 1989.

    Article  PubMed  CAS  Google Scholar 

  44. Luft F.C., Aronoff G.R., Sloan R.S., Fineberg N.S., Weinberger M.H. Calcium channel blockade with nitrendipine: effects on sodium homeostasis, the renin-angiotensin system, and the sympathetic nervous system in humans. Hypertension 7: 438, 1985.

    PubMed  CAS  Google Scholar 

  45. McKenna T.J., Sequeira S.J., Heffeman A., Chambers J., Culmingham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary aldosteronism. J. Clin. Endocrinol. Metab. 73: 952, 1991.

    Article  PubMed  CAS  Google Scholar 

  46. Collins R.D., Weinberger M.H., Dowdy A.J., Nokes G.W., Gonzales C.M., Leutscher J.A. Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. J. Clin. Invest. 49: 1415, 1970.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  47. Lifton R.P., Dluhy R.G., Powers M., Rich G.M., Gook S., Ulick S., Lalouel J.M. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262, 1992.

    Article  PubMed  CAS  Google Scholar 

  48. Lifton R.P., Dluhy R.G., Powers M., Rich G.M., Gutkin M., Fallo F., Gill J.R. Jr. Feld L., Ganguly A., Laidlaw J.C., Murnagham D.J., Kaufman C., Stockigt J.R., Ulick S., Lalouel J.M. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nature Genetics. 2: 66, 1992.

    Article  PubMed  CAS  Google Scholar 

  49. Jonsson J.R., Klemm S.A., Tunny T.J., Stowasser M., Gordon R.D. A new genetic test for familial hyperaldosteronism tye I aids in the detection of curable hypertension. Biochem. & Biophy. Res. Comm. 207: 565, 1995.

    Article  CAS  Google Scholar 

  50. Soma R., Miyamori I., Nakagawa A., Matsubara T., Takasaky H., Morise T., Koni I., Takeda R., Kobayashi T. Possible association of aldosterone producing adenoma and non-fuctioning adrenal tumour. J. Endocrinol. Invest. 12: 183, 1989.

    Article  PubMed  CAS  Google Scholar 

  51. Vaughan N.J.A., Jowett T.P., Slater J.D.H., Wiggins R.C., Lightman S.L., Ma J.T.C., Payne N.N. The diagnosis of primary aldosteronism. Lancet i: 120, 1981.

    Article  Google Scholar 

  52. Rutherford J.C., Stowasser M., Klemm S.A., Tunny T.J., Gordon R.D. Laparoscopic adrenalectomy for adrenal tumours causing hypertension and for “incidentalomas” of the adrenal on CT scanning. Clin. Exper. Pharmacol. Physiol. 1995 (in press).

  53. Ross N.S., Aron D.C. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. New Engl. J. Med. 323: 1401, 1990.

    Article  PubMed  CAS  Google Scholar 

  54. Francis I.R., Gross M.D., Shapiro B., Korobkin M., Quint L.E. Integrated imagery of adrenal disease. Radiology 184: 1, 1992.

    PubMed  CAS  Google Scholar 

  55. Osella G., Terzolo M., Borretta G., Magro G., Ali A., Piovesan A., Paccotti P., Angeli A. Endocrine evaluation of the incidentally discovered adrenal masses (Incidentalomas). J. Clin. Endocrinol. Metab. 79: 1532, 1994.

    Article  PubMed  CAS  Google Scholar 

  56. Herrara M.F., Grant C.S., van Heerden J.A., Sheedy P.E., Ilstrup D.M. Incidentally discovered adrenal tumours: an institutional perspective. Surgery 110: 1014, 1991.

    Google Scholar 

  57. Hamwi G.J., Serbin R.A., Kruger F.A. Does adrenocortical hyperplasia result in adrenocortical carcinoma? N. Engl. J. Med. 257: 1153, 1957.

    Article  CAS  Google Scholar 

  58. Sutherland D.J.A., Ruse J.L., Laidlaw J.C. Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can. Med. Assoc. J. 95: 1109, 1966.

    PubMed Central  PubMed  CAS  Google Scholar 

  59. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 16: 363, 1954.

    Article  PubMed  CAS  Google Scholar 

  60. Skogseid B., Larsson C., Lindgren P-G., Kvanta E., Rastad J., Theodorsson E., Wide L., Wilander E., Oberg K. Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type I. J. Clin. Endocrinol. Metab. 75: 76, 1992.

    PubMed  CAS  Google Scholar 

  61. Beckers A., Abs R., Willems P.J., van der Auwea B., Kovacs K., Reznik M., Stevenaert A. Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type I (MEN-I): Loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN-I locus. J. Clin. Endocrinol. Metab. 75: 564, 1992.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, R.D. Primary aldosteronism. J Endocrinol Invest 18, 495–511 (1995). https://doi.org/10.1007/BF03349761

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349761

Key-words

Navigation